Daniel D. Long - Oct 24, 2024 Form 3 Insider Report for Septerna, Inc. (SEPN)

Role
SVP, Drug Discovery
Signature
/s/ Ran Xiao, Attorney-in-Fact
Stock symbol
SEPN
Transactions as of
Oct 24, 2024
Transactions value $
$0
Form type
3
Date filed
10/24/2024, 09:20 PM

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding SEPN Common Stock 92.9K Oct 24, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding SEPN Stock Option (Right to Buy) Oct 24, 2024 Common Stock 20.9K $2.76 Direct F1
holding SEPN Stock Option (Right to Buy) Oct 24, 2024 Common Stock 13.9K $2.76 Direct F2
holding SEPN Stock Option (Right to Buy) Oct 24, 2024 Common Stock 40.6K $6.81 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/48th of the shares subject to such option vest and become exercisable in substantially equal monthly installments on each monthly anniversary of August 1, 2023, subject to the Reporting Person's continuous service to the Issuer on each such date.
F2 1/48th of the shares subject to such option vest and become exercisable in substantially equal monthly installments on each monthly anniversary of March 1, 2024, subject to the Reporting Person's continuous service to the Issuer on each such date.
F3 1/48th of the shares subject to such option vest and become exercisable in substantially equal monthly installments on each monthly anniversary of October 28, 2024, contingent upon the consummation of the Issuer's initial public offering, and subject to the Reporting Person's continuous service to the Issuer on each such date.

Remarks:

Exhibit 24 - Power of Attorney